Identification of the FcεRI-activated tyrosine kinases Lyn, Syk, and Zap-70 in human basophils

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 2, 1998, Pages 304-315

  Kepley, Christopher L ^a,b   Wilson, Bridget S ^a   Oliver, Janet M ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Allergy; Basophils; IgE; IgE receptor; Signal transduction; Tyrosine kinases

Indexed keywords

FC RECEPTOR; PROTEIN TYROSINE KINASE; 3,3',4,5'-TETRAHYDROXYSTILBENE; ENZYME INHIBITOR; IMMUNOGLOBULIN E RECEPTOR; LYN PROTEIN-TYROSINE KINASE; PICEATANNOL; PROTEIN KINASE LYN; PROTEIN KINASE ZAP 70; STILBENE DERIVATIVE; TYRO3 PROTEIN, HUMAN; ZAP70 PROTEIN, HUMAN;

ARTICLE; BASOPHIL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; BASOPHIL DEGRANULATION TEST; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; HISTAMINE RELEASE; METABOLISM; PHOSPHORYLATION; WESTERN BLOTTING;

BASOPHIL DEGRANULATION TEST; BASOPHILS; BLOTTING, WESTERN; ENZYME ACTIVATION; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTAMINE RELEASE; HUMANS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, IGE; SRC-FAMILY KINASES; STILBENES; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 0031595219     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70100-9     Document Type: Article

References (89)

1. Maurer D, Fiebiger E, Reininger B, WolffoWiniski B, Jouvin M-H, Kilgus O, et al. Expression of functional high affinity inimunoglobulin E receptors (FcεRI) on monocytes of atopic individuals. J Exp Med 1994;179:745-50.
2. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, et al. High-affinity IgE receptor on eosinophils is involved in defense against parasites. Nature 1994;367:183-6.
3. Wang B, Rieger A, Kilgus O, Ochiai K, Maurer D, Fodinger D, et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via FcεRI. J Exp Med 1992;175:1353-65.
4. Maurer D, Fiebiger E, Ebner C, Reininger B, Fischer GF, Wichlas S, et al. Peripheral blood dendritic cells express FcεRI as a complex composed of FcεRIα- and FcεRI-gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996;157:607-16.
5. Bieber T, Salle H, Wollenberg A, Hakimi J, Chizzonite R, Ring J, et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FcεRI). J Exp Med 1992;175:1285-90.
6. Eiseman E, Bolen JB. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature 1992;355:78-80.
7. Hutchcroft JE, Geahlen RL, Deanin GG, Oliver JM. FcεRI-mediated tyrosine phosphorylation and activation of the 72-kDa protein-tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells. Proc Natl Acad Sci U S A 1992;89:9107-11.
8. Benhamou M, Ryba NJ, Kihara H, Nishikata H, Siraganian RP. Protein-tyrosine kinase p72syk in high affinity IgE receptor signaling: identification as a component of pp72 and association with the receptor gamma chain after receptor aggregation. J Biol Chem 1993;268:23318-24.
9. Bochner BS, Undem BJ, Lichtenstein LM. Immunological aspects of allergic asthma. Annu Rev Immunol 1994;12:295-335.
10. Metzger H. The receptor with high affinity for IgE. Immunol Rev 1992;125:37-48.
11. 2 complex, in RBL-2H3 rat basophilic leukemia cells. Mol Biol Cell 1992;12:3176-82.
12. Barker SA, Caldwell KK, Pfeiffer JR, Wilson BS. Wortmannin-sensitive phosphorylation, translocation and activation of PLCγl, but not PLCγ2, in antigen-stimulated RBL-2H3 mast cells. Mol Cell Biol 1998;6:1145-58.
13. Park DJ, Min HK, Rhee SG. IgE-induced tyrosine phosphorylation of phospholipase C-γ 1 in rat basophilic leukemia cells. J Biol Chem 1991;266:24237-40.
14. Barker S, Caldwell K, Hall A, Martinez AM, Pfeiffer JR, Oliver JM, et al. Wortmannin blocks lipid and protein kinase activities associated with PI-3-kinase and inhibits a specific subset of responses induced by FcεRI crosslinking. Mol Biol Cell 1995;6:1145-58.
15. Yano H, Nakanishi S, Kimura K, Hanai N, Saitoh Y, Fukui Y, et al. Inhibition of histamine secretion by Wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J Biol Chem 1993;268:25846-56.
16. Price DJ, Kawakami Y, Kawakami T, Rivnay B. Purification of a major tyrosine kinase from RBL-2H3 cells phosphorylating FcεRI γ-cytoplasmic domain and identification as the Btk tyrosine kinase. Biochim Biophys Acta 1995;1265:133-42.
17. Margolis B, Hu P, Katzav S, Li W, Oliver JM, Ullrich A, et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs. Nature 1992;356:71-4.
18. Turner H, Reif K, Rivera J, Cantrell DA. Regulation of the adapter molecule Grb2 by the FcεRI in the mast cell line RBL2H3. J Biol Chem 1995;270:9500-6.
19. rsk and pp70-S6 kinases in mouse mast cells by signaling through the c-kit receptor tyrosine kinase or FcεRI: rapamycin inhibits activation of pp70-S6 kinase and proliferation in mouse mast cells. Eur J Immunol 1993;23:3286-91.
20. Offermanns S, Jones SVP, Bombien E, Schultz G. Stimulation of mitogen-activated protein kinase activity by different secretory stimuli in rat basophilic leukemia cells. J Immunol 1994;152:250-61.
21. Santini F, Beaven MA. Tyrosine phosphorylation of a mitogen-activated protein kinase-like protein occurs at a late step in exocytosis: studies with tyrosine phosphatase inhibitors and various secretagogues in rat RBL-2H3 cells. J Biol Chem 1993;268:22716-22.
22. Oliver JM, Pfeiffer JR, Wilson BS. Regulation and roles of the membrane, cytoskeletal and adhesive responses of RBL-2H3 rat tumor mast cells to FcεRI crosslinking. In: Hamawy MM, editor. IgE receptor (FcεRI) in mast cells and basophils. Austin, Tex.: R.G. Landes; 1997. p. 139-66.
23. Warner JA, MacGlashan DW Jr. Signal transduction events in human basophils: a comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucylphenylalanine. J Immunol 1990;145:1897-905.
24. MacGlashan D Jr, Guo C-B. Oscillations in free cytosolic calcium during IgE-mediated stimulation distinguish human basophils from human mast cells. J Immunol 1991;147:2259-69.
25. Warner JA, MacGlashan DW Jr. Protein kinase C (PKC) changes in human basophils: IgE-mediated activation is accompanied by an increase in total PKC activity. J Immunol 1989;142:1669-77.
26. Knol EF, Koenderman L, Mul E, Verhoeven AJ, Roos D. Differential mechanisms in the stimulus-secretion coupling in human basophils: evidence for a protein-kinase-C-dependent and a protein-kinase-C-independent route. Agents Actions 1990;30:49-52.
27. MacGlashan DW Jr, Bochner BS, Warner JA. Graded changes in the response of individual human basophils to stimulation: distributional behavior of early activation events. J Leukoc Biol 1994;55:13-23.
28. Galli SJ, Dvorak AM, Dvorak HE. Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog Allergy 1984;34:1-141.
29. Dvorak AM, Newball HH, Dvorak HF, Lichtenstein LM. Antigen-induced IgE-mediated degranulation of human basophils. Lab Invest 1980;43:126-39.
30. Schroeder JT, MacGlashan DW Jr, Kagey-Sobotka A, White JM, Lichtenstein LM. Cytokine generation by human basophils. J Allergy Clin Immunol 1994;94:1189-95.
31. MacGlashan DW Jr. Signal transduction and cytokine production by human basophils. Chem Immunol 1995;61:88-113.
32. Sobotka AK, Dembo M, Goldstein B, Lichtenstein LM. Antigen-specific desensitization of human basophils. J Immunol 1979;122:511-7.
33. MacGlashan DW, Lichtenstein LM. Studies of antigen binding on human basophils, I: antigen binding and functional consequences. J Immunol 1983;130:2330-6.
34. MacGlashan DW Jr. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993;91:605-15.
35. Fox CC, Kagey-Sobotka A, Schleimer RP, Peters SP, MacGlashan DW Jr, Lichtenstein LM. Mediator release from human basophils and mast cells from lung and intestinal mucosa. Int Arch Allergy Appl Immunol 1985;77:130-6.
36. Chabay R, DeLisi C, Hook WA, Siraganian RP. Receptor cross-linking and histamine release in basophils. J Biol Chem 1980;255:4628-35.
37. Nguyen K-L, Gillis S, MacGlashan DW Jr. A comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking. J Allergy Clin Immunol 1990;85:1020-9.
38. Black KM, Lussier AM, Gion WR, Kasaian MT. Cytokine priming of human basophils: description of allergen 'nonreleasers.' Int Arch Allergy Immunol 1996;111:142-51.
39. Ishizaka T, Soto CS, Ishizaka K. Mechanisms of passive sensitization, III: number of IgE molecules and their receptor sites on human basophil granulocytes. J Immunol 1973;111:500-11.
40. Warner JA, Peters SP, Lichtenstein LM, Hubbard W, Yancey KB, Stevenson HC, et al. Differential release of mediators from human basophils: differences in arachidonic acid metabolism following activation by unrelated stimuli. J Leukocyte Biol 1989;45:558-71.
41. Massey WA, Randall TC, Kagey-Sobotka A, Warner JA, MacDonald SM, Gillis S, et al. Recombinant human IL-1α and -1β potentiate IgE-mediated histamine release from human basophils. J Immunol 1989;143:1875-80.
42. Bischoff SC, De Weck AL, Dahinden CA. Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci U S A 1990;87:6813-7.
43. Bischoff SC, Brunner T, De Weck AL, Dahinden CA. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990;172:1577-82.
44. Bischoff SC, Krieger M, Brunner T, Rot A, Tscharner V, Baggiolini M, et al. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors. Eur J Immunol 1993;23:761-7.
45. Dahinden CA, Krieger M, Brunner T, Bischoff SC. Basophil activation by members of the chemokine superfamily. Adv Exp Med Biol 1993;351:99-110.
46. Kaplan AP, Baeza M, Reddigari S, Kuna P. Histamine releasing factors. Clin Exp Allergy 1991;21(suppl. 1):8-16.
47. Kuna P, Reddigari SR, Rucinski D, Oppenheim JJ, Kaplan AP. Monocyte chemotactic and activating factor is a potent histamine-releasing factor forhuman basophils. J Exp Med 1992;175:489-93.
48. Reddigari SR, Kuna P, Miragliotta GF, Kornfeld D, Baeza ML, Castor CW, et al. Connective tissue-activating peptide-III and its derivative, neu-trophil-activating peptide-2, release histamine from human basophils. J Allergy Clin Immunol 1992;89:666-72.
49. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol 1993;150:1932-43.
50. Kepley CL, Craig SS, Schwartz LB. Identification and partial characterization of a unique marker for human basophils. J Immunol 1995;154:6548-55.
51. Kamps MP. Generation and use of anti-phosphotyrosine antibodies for immun ob lotting. Methods Enzymol 1991;201:101-10.
52. Riske F, Hakim J, Mallamaci M, Griffin M, Pilson B, Tobkes N, et al. High affinity human IgE receptor (FcεRI): analysis of functional domains of the α-subunit with monoclonal antibodies. J Biol Chem 1991;266:11245-51.
53. Taniguchi T, Kobayashi T, Kondo J, Takahashi K, Nakamura H, Suzuki J, et al. Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem 1991;266:15790-6.
54. Kepley C, Craig S, Schwartz L. Purification of human basophils by density and size alone. J Immunol Methods 1994;175:1-9.
55. Bjerke T, Nielsen S, Helgestad J, Nielsen BW, Schiotz PO. Purification of human blood basophils by negative selection using immunomagnetic beads. J Immunol Methods 1993;157:49-56.
56. Becker EL. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes. J Exp Med 1972;135:376-87.
57. Oliver JM, Burg DL, Wilson BS, McLaughlin JL, Geahlen RL. Inhibition of mast cell FcεRI-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J Biol Chem 1994;269:29697-703.
58. Wilson BS, Kapp N, Lee RJ, Pfeiffer JR, Martinez AM, Platt Y, et al. Distinct functions of the FcεRI γ and β subunits in the control of FcεRI-mediated tyrosine kinase activation and signaling responses in RBL-2H3 mast cells. J Biol Chem 1995;270:4013-22.
59. Law CL, Sidorenko SP, Chandran KA, Draves KE, Chan AC, Weiss A, et al. Molecular cloning of human Syk: A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. J Biol Chem 1994;269:12310-9.
60. Clark MR, Campbell KS, Kazlauskas A, Johnson SA, Hertz M, Potter TA, et al. The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. Science 1992;258:123-6.
61. Huby RDJ, Iwashima M, Weiss A, Ley SC. ZAP-70 protein tyrosine kinase is constitutively targeted to the T cell cortex independently of its SH2 domains. J Cell Biol 1997;137:1639-49.
62. Hamawy MM, Mergenhagen SE, Siraganian RP Protein tyrosine phosphorylation as a mechanism of signalling in mast cells and basophils. Cell Signal 1995;7:535-44.
63. Dembo M, Goldstein B. A model of cell activation and desensitization by surface immunoglobin: the case of histamine release from human basophils. Cell 1980;22:59-67.
64. Kagey-Sobotka A, MacGlashan DW, Lichtenstein LM. Role of receptor aggregation in triggering IgE-mediated reactions. Fed Proc 1982;41:12-6.
65. Stanley E, Ralph S, McEwen S, Boulet I, Holtzman DA, Lock P, et al. Alternatively spliced murine lyn mRNAs encode distinct proteins. Mol Cell Biol 1991;11:3399-406.
66. Yi TL, Bolen JB, Ihle JN. Hematopoietic cells express two forms of lyn kinase differing by 21 amino acids in the amino terminus. Mol Cell Biol 1991;11:2391-8.
67. Eiseman E, Bolen JB. src-related tyrosine protein kinases as signaling components in hematopoietic cells. Cancer Cells 1990;2:303-10.
68. Yamanashi Y, Mori S, Yoshida M, Kishimoto T, Inoue K, Yamamoto T, et al. Selective expression of a protein-tyrosine kinase, p561yn, in hematopoietic cells and association with production of human T-cell lymphotropic virus type I. Proc Natl Acad Sci U S A 1989;86:6538-42.
69. Hutchcroft JE, Harrison ML, Geahlen RL. Association of the 72-kDa protein-tyrosine kinase PTK72 with the B cell antigen receptor. J Biol Chem 1992;267:8613-9.
70. Agarwal A, Salem P, Robbins KC. Involvement of p72syk, a protein-tyrosine kinase, in Fcγ receptor signaling. J Biol Chem 1993;268:15900-5.
71. Taniguchi T, Kitagawa H, Yasue S, Yanagi S, Sakai K, Asahi M, et al. Protein-tyrosine kinase p72syk is activated by thrombin and is negatively regulated through Ca2+ mobilization in platelets. J Biol Chem 1993;268:2277-9.
72. Chan AC, Irving BA, Fraser JD, Weiss A. The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. Proc Natl Acad Sci USA 1991;88:9166-70.
73. Chan AC, van Oers NS, Tran A, Turka L, Law CL, Ryan JC, et al. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol 1994;152:4758-66.
74. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR-ζ chain. Cell 1992;71:649-62.
75. Bu JY, Shaw AS, Chan AC. Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance. Proc Natl Acad Sci U S A 1995;92:5106-10.
76. Park JG, Schreiber AD. Determinants of the phagocytic signal mediated by the type IIIA Fcγ receptor, FcγRIIIA: sequence requirements and interaction with protein-tyrosine kinases. Proc Natl Acad Sci USA 1995;92:7381-5.
77. Howard FD, Rodewald HR, Kinet JP, Reinherz EL. CD3 ζ subunit can substitute for the subunit of Fcε receptor type I in assembly and functional expression of the high-affinity IgE receptor: evidence for inter-receptor complementation. Proc Natl Acad Sci U S A 1990;87:7015-9.
78. Shores E, Flamand V, Tran T, Grinberg A, Kinet JP, Love PE. FcεRI γ can support T cell development and function in mice lacking endogenous TCR ζ-chain. J Immunol 1997;159:222-30.
79. Benhamou M, Feuillard J, Lortholary O, Bourgeois C, Michel L, LeGoff, L, et al. Protein tyrosine kinases in activation signal of human basophils through the immunoglobulin E receptor type 1. J Leukoc Biol 1996;59:461-70.
80. Marone G, Kagey-Sobotka A, Lichtenstein LM. IgE-mediated histamine release from human basophils: differences between antigen E- and anti-IgE-induced secretion. Int Arch Allergy Appl Immunol 1981;65:339-48.
81. MacGlashan DW Jr, Peters SP, Warner J, Lichtenstein LM. Characteristics of human basophil sulfidopeptide leukotreine release: releasability defined as the ability of basophils to respond to dimeric cross-links. J Immunol 1986;136:2231-9.
82. Lichtenstein LM, Levy DA, Ishizaka K. In vitro reversed anaphylaxis: characteristics of anti-IgE mediated histamine release. Immunology 1970;19:831-42.
83. Maeyama K, Hohman RJ, Ali H, Cunha-Melo JR, Beaven MA. Assessment of IgE-receptor function through measurement of hydrolysis of membrane inositol phospholipids: new insights on the phenomena of biphasic antigen concentration-response curves and desensitization. J Immunol 1988;140:3919-27.
84. Weetall M, Holowka D, Baird B. Heterologous desensitization of the high affinity receptor for IgE (FcεRI) on RBL cells. J Immunol 1993;150:4072-83.
85. McCloskey MA. Immobilization of Fcε receptors by wheat germ agglutinin: receptor dynamics in IgE-mediated signal transduction. J Immunol 1993;151:3237-51.
86. Wofsy C, Kent UM, Mao SY, Metzger H, Goldstein B. Kinetics of tyrosine phosphorylation when IgE dimers bind to Fc-ε receptors on rat basophilic leukemia cells. J Biol Chem 1995;270:20264-72.
87. Paolini R, Serra A, Kinet JP. Persistence of tyrosine-phosphorylated FcεRI in deactivated cells. J Biol Chem 1996;271:15987-92.
88. Brown MT, Cooper JA. Regulation, substrates and functions of src. Biochim Biophys Acta 1996;1287:121-49.
89. Osborne MA, Zenner G, Lubinus M, Zhang X, Songyang Z, Cantley LC, et al. The inositol 5′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J Biol Chem 1996;271:29271-8.